<DOC>
	<DOC>NCT01245374</DOC>
	<brief_summary>This study is conducted in Europe. The aim of this study is to compare the easiness of use of Norditropin NordiFlex速 device to the device previously used by patients or parents.</brief_summary>
	<brief_title>Norditropin NordiFlex速 Device Compared to the Device Previously Used by Patients or Parents</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Children who can receive Norditropin速 (somatropin) treatment according to the product labelling Treated with growth hormone for at least one year Contraindications to Norditropin速 growth hormone therapy Known or suspected hypersensitivity to somatropin or related products The receipt of any investigational medicinal product within 3 months prior to study start Life threatening disease, for example cancer Pregnancy or the intention of becoming pregnant</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>